Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
73,26 USD | +1,57% | +1,23% | +2,29% |
23/04 | INTRA-CELLULAR THERAPIES, INC. : Canaccord Genuity nog altijd een koopadvies | ZM |
23/04 | INTRA-CELLULAR THERAPIES, INC. : Een koopadvies van Needham & Co. | ZM |
Vakgebied
Aantal werknemers: 610
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Small Molecule Drugs
100,0
%
| 250 | 100,0 % | 464 | 100,0 % | +85,51% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 250 | 100,0 % | 464 | 100,0 % | +85,51% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sharon Mates
CEO | Chief Executive Officer | 71 | 29-08-13 |
Director of Finance/CFO | 67 | 29-08-13 | |
Michael Halstead
PSD | President | 51 | 01-07-14 |
Willie Earley
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-22 |
Suresh Durgam
CTO | Chief Tech/Sci/R&D Officer | - | - |
Karen Sheehy
CMP | Compliance Officer | 62 | 02-07-19 |
Robert Davis
CTO | Chief Tech/Sci/R&D Officer | 73 | 01-11-15 |
Juan F. Sanchez
IRC | Investor Relations Contact | - | 10-03-14 |
John A. Bardi
LAW | General Counsel | - | 26-03-19 |
General Counsel | - | 01-09-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rory Riggs
BRD | Director/Board Member | 71 | 08-01-14 |
Joel Marcus
BRD | Director/Board Member | 76 | 29-08-13 |
Director/Board Member | 67 | 08-01-14 | |
Sharon Mates
CEO | Chief Executive Officer | 71 | 29-08-13 |
Rene Salas
BRD | Director/Board Member | 62 | 20-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 104 256 524 | 101 717 520 ( 97,56 %) | 0 | 97,56 % |
Bedrijfsgegevens
Intra-Cellular Therapies, Inc.
430 East 29th Street Suite 900
10016, New York
+646 440 9333
http://www.intracellulartherapies.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,29% | 7,72 mld. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,36 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |
- Beurs
- Aandelen
- Koers ITCI
- Onderneming Intra-Cellular Therapies, Inc.